6-K ·Filed Jun 29, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No immediate trading implications. Monitor upcoming earnings or business development filings for material updates.
TAK drugs
TAK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$15.98
T+0 close · Jun 29, 2026 · via day close
Latest settled
+18.59%
T+60 · $18.95
Vs SPY
+14.20%
α at T+60
Horizons
All settled
through T+60
- T+0 · Jun 29 $15.98entry
- T+1 · 5mo ago +0.31%α −0.47% · $16.03
- T+5 · 4mo ago +5.69%α +4.31% · $16.89
- T+20 · 4mo ago +7.88%α +8.16% · $17.24
- T+60 · 8w ago +18.59%α +14.20% · $18.95
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Takeda filed a 6-K furnishing an English translation of its updated Articles of Incorporation, effective June 29, 2026. The amendments are routine governance updates with no financial or operational impact.
Key Facts
- Filed updated Articles of Incorporation on June 29, 2026.
- No changes to authorized shares, business purpose, or governance structure material to shareholders.
- Routine administrative filing for a foreign private issuer.
Financial Impact
None; no financial figures disclosed.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
68% bullish (19 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001395064-26-000189 |
| Document: form6k_062926.htm | 0001395064-26-000189 |
| Document: 0001395064-26-000189-index-headers.html | 0001395064-26-000189 |
| Document: 0001395064-26-000189-index.html | 0001395064-26-000189 |
| Document: 0001395064-26-000189.txt | 0001395064-26-000189 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
Showing 10 of 18
US Market Status
Market Closed · Opens in 9h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers